keep away from direct sunlight,keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AVG-233 is an orally available RNA-dependent RNA polymerase (RdRp) inhibitor with antiviral activity that blocks respiratory syncytial virus and SARS-CoV-2 replication.AVG-233 is used in the study of respiratory syncytial virus infections.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,400.00 | |
50 mg | 8-10 weeks | $ 1,820.00 | |
100 mg | 8-10 weeks | $ 2,500.00 |
Description | AVG-233 is an orally available RNA-dependent RNA polymerase (RdRp) inhibitor with antiviral activity that blocks respiratory syncytial virus and SARS-CoV-2 replication.AVG-233 is used in the study of respiratory syncytial virus infections. |
In vitro | AVG-233 (20 μM) exhibits nanomolar activity against both laboratory-adapted RSV strains and clinical RSV isolates[1]. |
In vivo | In female Balb/cJ mice with recRSV-mKate xenograft, AVG-233 (50 and 100 mg/kg; oral gavage; once) reduced lung viral load by 0.89 log10 TCID50 (median tissue culture infectious dose)/mL[2]. |
Molecular Weight | 487.94 |
Formula | C26H22ClN5O3 |
CAS No. | 2151937-80-1 |
keep away from direct sunlight,keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (61.48 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AVG-233 2151937-80-1 Cell Cycle/Checkpoint DNA Damage/DNA Repair Microbiology/Virology RSV DNA/RNA Synthesis inhibitor inhibit